(IN BRIEF) CNP Assurances has joined Acteurs de La French Care to support the development of workplace preventive healthcare in France. The partnership will focus on improving awareness, early detection, evidence sharing and structured prevention practices for the country’s 27 … Read the full press release →
Posted in Business, France, Healthcare, Insurance, Security & Safety, Society
Tagged absenteeism, Acteurs de La French Care, Agence de l’innovation en santé, Antoine Tesnière, Asterès, Christophe Harrigan, CNP Assurances, CNP Assurances Backs 2026 Programme to Improve Health Prevention for Employees, CNP Assurances Supports New Workplace Health Prevention Agenda in France, employee health, employer health initiatives, France, Grand pôle financier public, health system savings, healthcare expenditure, healthcare policy, New French Care Partnership Links Social Protection and Workplace Health Prevention, occupational health, PariSanté Campus, preventive healthcare, return on investment, sedentary work, social determinants of health, social protection, workplace prevention, workplace wellbeing
(IN BRIEF) EMA, together with the European Commission and the Heads of Medicines Agencies, has released the first report measuring progress toward the EU’s 2030 clinical trial targets. The report shows that 19 additional multinational clinical trials have been authorised … Read the full press release →
Posted in Business, European Union, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Accelerating Clinical Trials in the EU, ACT EU, biotechnology, clinical research, clinical trial authorisation, clinical trial reform, clinical trial timelines, drug development, EMA, EMA and EU Authorities Advance Clinical Research Reforms Under 2030 Trial Strategy, EMA Highlights Early Progress in EU Efforts to Expand and Accelerate Clinical Trials, EU Biotech Act, EU clinical trials, EU Reports Early Progress Toward 2030 Clinical Trial Goals, European Commission, European Medicines Agency, European Union, FAST-EU, Heads of Medicines Agencies, Healthcare Innovation, healthcare policy, healthcare regulation, HMA, innovative medicines, life sciences, medical research, Medicine Development, multinational clinical trials, Patient Recruitment, pharmaceutical innovation, pharmaceutical sector, regulatory transparency, research investment
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
